title: Evolving Treatment Options for Lung Cancer.
authors.affiliation: Thoracic Oncology Program, Washington University, 660 South Euclid Avenue, Box 8056, St Louis, MO 63110, USA. Electronic address: dmorgens@wustl.edu.
authors.forename: Daniel
authors.initials: D
authors.lastname: Morgensztern
authors.affiliation: Yale School of Medicine, Yale Cancer Center, Smilow Cancer Hospital at Yale-New Haven, New Haven, CT 06519, USA. Electronic address: Roy.herbst@yale.edu.
authors.forename: Roy S
authors.initials: RS
authors.lastname: Herbst
mesh_terms: D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D008175:Lung Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends
chemical_list: D014408:Biomarkers, Tumor